Abstract
INTRODUCTION
This study investigates the efficiency of low level laser therapy (LLLT) in the treatment of clinical symptoms and improvement of the quality of life in patients diagnosed with primary fibromyalgia syndrome (FMS).
METHODS
Sixty primary FMS patients were randomly divided into two groups: active gallium-arsenide (GaAs) laser (30 patients) and placebo laser (30 patients). All the patients were assessed in terms of recovery rates in tender point quantity, pain, morning stiffness, sleep disorder, fatigue, muscle spasm, subjective swelling and paresthesia. Assessment of the quality of life was performed according to the fibromyalgia impact questionnaire (FIQ). Two minutes of 4,4 J/cm2 Ga-As laser therapy to every point was applied to the patients in the active laser group for 10 days. For placebo therapy, the application was applied for the same period of time without radiating any laser beams.
RESULTS
After the treatment, statistically significant recovery was observed in both groups in terms of all parameters.
DISCUSSION AND CONCLUSION
Our results suggest that application of LLLT is effective in the treatment of FMS and emotional factors may play an important role in its etiopathogenesis.